SHARE PURCHASE AGREEMENT
This Share Purchase Agreement ("Agreement"), dated as of March 2, 2000,
among Xxxx Xxxxx, Xxxxx Xxxxxxx, Wintrade Fund, LLC, Xxxxxxxx Xxxxxxx and Xxxx
Xxxx, (SELLERS), Investra Enterprises, Inc. ("IEI") and Pathobiotek Diagnostics,
Inc., (BUYER) a Texas Corporation.
W I T N E S S E T H:
A. WHEREAS, INVESTRA ENTERPRISES, INC. ("IEI") is a corporation duly
organized under the laws of the State of Florida.
B. WHEREAS, BUYER wishes to purchase 100% of the outstanding common shares
of IEI free and clear of liens and encumbrances from SELLER.
C. WHEREAS, the parties hereto wish to enter into this Agreement, pursuant
to the provisions of the Texas Statutes.
NOW, THEREFORE, it is agreed among the parties as follows:
ARTICLE I
THE CONSIDERATION
1.1 Subject to the conditions set forth herein on the "Closing Date"
(as herein defined), SELLER shall sell and BUYER shall purchase 672,000 common
shares of IEI common stock. The transactions contemplated by this Agreement
shall be completed at a closing ("Closing") on a closing date ("Closing Date")
on or before March 5, 2000. The purchase price for the IEI shares to be paid by
BUYER to SELLERS is $150,000, $25,000 of which is paid herewith and $125,000
which shall be delivered at closing.
On the Closing Date, all of the documents to be furnished pursuant to
this Agreement, including the documents to be furnished pursuant to Article VI
of this Agreement, shall be delivered to M.A. Xxxxxxx, to be held in escrow
until all closing conditions hereunder have been met or the date of termination
of this Agreement, but no longer than 1 day after closing date, whichever first
occurs, and thereafter shall be promptly distributed to the parties as their
interests may appear.
1.2 Concurrent with the execution hereof, BUYER shall deposit or cause
to be deposited with M.A. Xxxxxxx as a non-refundable consideration for this
agreement, the sum of $25,000. Further, the sum of $125,000 shall be paid at
closing for delivery to SELLERS upon receipt of the shares (672,000) of IEI
common stock, constituting 100% of the outstanding common stock of IEI.
ARTICLE II
CONVEYANCE OF SHARES
2.1 The shares of no par value common stock of IEI shall be delivered
and conveyed by SELLERS to BUYER at closing by SELLERS with duly executed stock
powers, upon receipt of the cash consideration by SELLERS.
2.2 SELLERS represent that no outstanding options or warrants for
unissued shares exist for IEI.
ARTICLE III
REPRESENTATIONS, WARRANTIES AND COVENANTS OF SELLER AS TO IEI
SELLERS hereby represent, warrants and covenants to BUYER and will cause
IEI to so represent and warrant, except as stated in the IEI Disclosure
Statement, as follows:
3.1 IEI is a corporation duly organized, validly existing and in good
standing under the laws of the State of Florida, and has the corporate power and
authority to own or lease its properties and to carry on its business as it is
now being conducted. The Articles of Incorporation and Amendments and Bylaws of
IEI, copies of which have been delivered to BUYER, are complete and accurate,
and the minute books of IEI contain a record, which is complete and accurate in
all material respects, of all meetings, and all corporate actions of the
shareholders and Board of Directors of IEI.
3.2 The aggregate number of shares which IEI is authorized to issue is
50,000,000 shares of common stock with no par value per share, of which
approximately 672,000 shares of such common stock will be issued and
outstanding, fully paid and non-assessable, at closing under this agreement. IEI
has no outstanding options, warrants or other rights to purchase, or subscribe
to, or securities convertible into or exchangeable for any shares of capital
stock.
3.3 IEI and SELLERS have complete and unrestricted power to enter into
and, upon the appropriate approvals as required by law, to consummate the
transactions contemplated by this Agreement.
3.4 Neither the making of nor the compliance with the terms and
provisions of this Agreement and consummation of the transactions contemplated
herein by IEI will conflict with or result in a breach or violation of the
Articles of Incorporation or Bylaws of IEI.
3.6 IEI has delivered to BUYER Audited financial statements of IEI
dated August 31, 1999. At or prior to closing IEI shall have filed its 10Q for
November 30, 1999, including unaudited financial statements. All such
statements, herein sometimes called "IEI Financial Statements" are (and will be)
complete and correct in all material respects and, together with the notes to
these financial statements, present fairly the financial position and results of
operations of IEI of the periods indicated. All financial statements of IEI will
have been prepared in accordance with generally accepted accounting principles.
3.7 Since the dates of the IEI Financial Statements, there have not
been any material adverse changes in the business or condition, financial or
otherwise, of IEI. IEI does not have any material liabilities or obligations,
secured or unsecured except as shown on updated financials (whether accrued,
absolute, contingent or otherwise).
3.8 There are no pending legal proceedings involving IEI, there are no
legal proceedings or regulatory proceedings involving material claims pending,
or, to the knowledge of the SELLERS, threatened against IEI or affecting any of
its assets or properties, and IEI is not in any material breach or violation of
or default under any contract or instrument to which IEI is a party, and no
event has occurred which with the lapse of time or action by a third party could
result in a material breach or violation of or default by IEI under any contract
or other instrument to which IEI is a party or by which it or any of its
properties may be bound or affected, or under its Articles of Incorporation or
Bylaws, nor is there any court or regulatory order pending, applicable to IEI.
3.9 IEI shall not enter into or consummate any transactions prior to
the Closing Date other than in the ordinary course of business and will pay no
dividend, or increase the compensation of officers and will not enter into any
agreement or transaction which would adversely affect its financial condition.
3.10 IEI is not a party to any contract performable in the future.
3.11 The representations and warranties of SELLERS and IEI shall be
true and correct as of the date hereof and as of the Closing Date.
3.12 IEI shall deliver to BUYER, all of its corporate books and records
for review. IEI will also deliver to BUYER on or before the Closing Date any
reports relating to the financial and business condition of IEI which occur
after the date of this Agreement and any other reports sent generally to its
shareholders after the date of this Agreement.
3.13 IEI has no employee benefit plan in effect at this time.
3.14 No representation or warranty by IEI or SELLERS in this Agreement,
the IEI Disclosure Statement or any certificate delivered pursuant hereto
contains any untrue statement of a material fact or omits to state any material
fact necessary to make such representation or warranty not misleading.
3.15 SELLERS or IEI has delivered, to BUYER true and correct copies of
the 10-SB and each of its other reports to shareholders and filing with the
Securities and Exchange Commission ("SEC") for the year ended December 31, 1999.
IEI will also deliver to BUYER on or before the Closing Date any reports
relating to the financial and business condition of IEI which are filed with the
SEC after the date of this Agreement and any other reports sent generally to its
shareholders after the date of this Agreement.
3.16 IEI has duly filed all reports required to be filed by it under
the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934,
as amended, (the "Federal Securities Laws"). No such reports, or any reports
sent to the shareholders of IEI generally, contained any untrue statement of
material fact or omitted to state any material fact required to be stated
therein or necessary to make the statements in such report, in light of the
circumstances under which they were made, not misleading.
3.17 SELLERS hereby covenant that during the contract period, prior to
closing, IEI will not take any board action without BUYER's approval in writing,
pending selection of new officers and directors at closing.
3.18 SELLERS own 672,000 IEI shares being sold to the BUYER free and
clear of any liens and encumbrances and may transfer such shares without the
consent of any third party.
ARTICLE IV
OBLIGATIONS OF THE PARTIES PENDING THE CLOSING DATE
4.1 At all times prior to the Closing Date during regular business
hours, each party will permit the other to examine its books and records and the
books and records of its subsidiaries and will furnish copies thereof on
request. It is recognized that, during the performance of this Agreement, each
party may provide the other parties with information which is confidential or
proprietary information. During the term of this Agreement, and for four years
following the termination of this Agreement, the recipient of such information
shall protect such information from disclosure to persons, other than members of
its own or affiliated organizations and its professional advisers, in the same
manner as it protects its own confidential or proprietary information from
unauthorized disclosure, and not use such information to the competitive
detriment of the disclosing party. In addition, if this Agreement is terminated
for any reason, each party shall promptly return or cause to be returned all
documents or other written records of such confidential or proprietary
information, together with all copies of such writings and, in addition, shall
either furnish or cause to be furnished, or shall destroy, or shall maintain
with such standard of care as is exercised with respect to its own confidential
or proprietary information, all copies of all documents or other written records
developed or prepared by such party on the basis of such confidential or
proprietary information. No information shall be considered confidential or
proprietary if it is (a) information already in the possession of the party to
whom disclosure is made, (b) information acquired by the party to whom the
disclosure is made from other sources, or (c) information in the public domain
or generally available to interested persons or which at a later date passes
into the public domain or becomes available to the party to whom disclosure is
made without any wrongdoing by the party to whom the disclosure is made.
4.2 SELLERS and BUYER shall promptly provide each other with
information as to any significant developments in the performance of this
Agreement, and shall promptly notify the other if it discovers that any of its
representations, warranties and covenants contained in this Agreement or in any
document delivered in connection with this Agreement was not true and correct in
all material respects or became untrue or incorrect in any material respect.
4.3 All parties to this Agreement shall take all such action as may be
reasonably necessary and appropriate and shall use their best efforts in order
to consummate the transactions contemplated hereby as promptly as practicable.
ARTICLE V
PROCEDURE FOR CLOSING
5.1 At the Closing Date, the purchase and Sale shall be effected with
common stock certificates of IEI being delivered duly executed for 672,000
shares of common stock to BUYER and the delivery of $150,000 in a cashier's
check to SELLERS from BUYER, together with delivery of all other agreements,
schedules, warranties and representations set forth in this Agreement.
ARTICLE VI
CONDITIONS PRECEDENT TO THE
CONSUMMATION OF THE PURCHASE
The following are conditions precedent to the consummation of the
Agreement on or before the Closing Date:
6.1 SELLERS shall have performed and complied with all of its
respective obligations hereunder which are to be complied with or performed on
or before the Closing Date and SELLERS and IEI and BUYER shall provide one
another at the Closing with a certificate to the effect that such party has
performed each of the acts and undertakings required to be performed by it on or
before the Closing Date pursuant to the terms of this Agreement.
6.2 No action, suit or proceeding shall have been instituted or shall
have been threatened before any court or other governmental body or by any
public authority to restrain, enjoin or prohibit the transactions contemplated
herein, or which might subject any of the parties hereto or their directors or
officers to any material liability, fine, forfeiture or penalty on the grounds
that the transactions contemplated hereby, the parties hereto or their directors
or officers, have violated any applicable law or regulation or have otherwise
acted improperly in connection with the transactions contemplated hereby, and
the parties hereto have been advised by counsel that, in the opinion of such
counsel, such action, suit or proceeding raises substantial questions of law or
fact which could reasonably be decided adversely to any party hereto or its
directors or officers.
6.3 All actions, proceedings, instruments and documents required to
carry out this Agreement and the transactions contemplated hereby and the form
and substance of all legal proceedings and related matters shall have been
approved by counsel for BUYER.
6.4 The representations and warranties made by BUYER and SELLERS in
this Agreement shall be true as though such representations and warranties had
been made or given on and as of the Closing Date, except to the extent that such
representations and warranties may be untrue on and as of the Closing Date
because of (1) changes caused by transactions suggested or approved in writing
by BUYER or (2) events or changes (which shall not, in the aggregate, have
materially and adversely affected the business, assets, or financial condition
of IEI during or arising after the date of this Agreement.)
6.5 All outstanding liabilities of IEI shall have been paid and
released prior to closing.
6.6 The Share Exchange Agreement between IEI and the BUYER which is
currently being negotiated will close concurrently with the closing hereof.
ARTICLE VII
TERMINATION AND ABANDONMENT
7.1 Anything contained in this Agreement to the contrary
notwithstanding, the Agreement may be terminated and abandoned at any time prior
to the Closing Date:
(a) By mutual consent of parties;
(b) By either party, if any condition set forth in Article VI relating to
the other party has not been met or has not been waived;
(c) By BUYER, if any suit, action or other proceeding shall be pending or
threatened by the federal or a state government before any court or governmental
agency, in which it is sought to restrain, prohibit or otherwise affect the
consummation of the transactions contemplated hereby;
(d) By any party, if there is discovered any material error, misstatement
or omission in the representations and warranties of another Party;
(e) By any party if the Agreement Closing Date is not within 30 days from
the date hereof; or
7.2 Any of the terms or conditions of this Agreement may be waived at
any time by the party which is entitled to the benefit thereof, by action taken
by him or the Board of Directors, provided; however, that such action shall be
taken only if, in the judgment of the Board of Directors or Party taking the
action, such waiver will not have a materially adverse effect on the benefits
intended under this Agreement to the party waiving such term or condition.
7.3 The deposit of $25,000 paid as consideration herefore shall be
non-refundable if this transaction does not close due to the failure of the
BUYER to perform under the terms and conditions of this Agreement. If this
transaction does not close due to the failure of the SELLERS to perform under
the terms and conditions of this Agreement or due to the breach by IEI of its
representations and warranties under this agreement, the deposit shall be
returned to the BUYER.
ARTICLE VIII
TERMINATION OF REPRESENTATION AND
WARRANTIES AND CERTAIN AGREEMENTS
8.1 The respective representations and warranties of the parties hereto
shall expire with, and be terminated and extinguished by consummation of the
Agreement; provided, however, that the covenants and agreements of the parties
hereto shall survive in accordance with their terms.
ARTICLE IX
MISCELLANEOUS
9.1 This Agreement embodies the entire agreement between the parties,
and there have been and are no agreements, representations or warranties among
the parties other than those set forth herein or those provided for herein.
9.2 To facilitate the execution of this Agreement, any number of
counterparts hereof may be executed, and each such counterpart shall be deemed
to be an original instrument, but all such counterparts together shall
constitute but one instrument.
9.3 All parties to this Agreement agree that if it becomes necessary or
desirable to execute further instruments or to make such other assurances as are
deemed necessary, the party requested to do so will use its best efforts to
provide such executed instruments or do all things necessary or proper to carry
out the purpose of this Agreement.
9.4 This Agreement may be amended upon approval of the Board of
Directors of BUYER and SELLERS.
9.5 Any notices, requests, or other communications required or
permitted hereunder shall be delivered personally or sent by overnight courier
service, fees prepaid, addressed as follows:
To SELLERS:
copy to: Xxxxxxx X. Xxxxxxx
Attorney at Law
00000 X. 00xx Xxx., #000
Xxxxx Xxxxx, XX 00000
To BUYER:
Pathobiotek Diagnostics, Inc.
c/o Xxxxxx X. Xxxxxxx
0000 XX 000 Xxxxx, Xxx. X-000
Xxxxxxx, XX 00000
copy to:
or such other addresses as shall be furnished in writing by any party, and any
such notice or communication shall be deemed to have been given as of the date
received.
9.6 No press release or public statement will be issued relating to the
transactions contemplated by this Agreement without prior approval of BUYER and
SELLERS. However, IEI may issue at any time any press release or other public
statement it believes on the advice of its counsel it is obligated to issue to
avoid liability under the law relating to disclosures, but the party issuing
such press release or public statement shall make a reasonable effort to give
the other party prior notice of and opportunity to participate in such release
or statement.
9.7 Concurrent with the closing hereunder, BUYER shall cause IEI to
issue to the SELLERS Options to purchase a total of 100,000 shares of common
stock of IEI for a period of one year after the closing at a price of $.50 per
share, and shall grant piggyback registration rights therewith.
IN WITNESS WHEREOF, the parties have set their hands and seals this 2nd
day of March, 2000.
SELLERS:
/s/Xxxxxxxx Xxxxxxx
Xxxxxxxx Xxxxxxx
/s/Xxxxx Xxxxxxx
Xxxxx Xxxxxxx
Wintrade Fund, LLC
By: /s/Xxxxx Xxxxxxx
Xxxxx Xxxxxxx
/s/Xxx Xxxx
Xxx Xxxx
/s/Xxxx Xxxxx
Xxxx Xxxxx
Investra Enterprises, Inc.
By:/s/Xxxxx Xxxxxxx
Xxxxx Xxxxxxx, President
BUYER:
Pathobiotek Diagnostics, Inc.
By:/s/Xxxxxx X. Xxxxxxx
Xxxxxx X. Xxxxxxx, President
